Source:http://linkedlifedata.com/resource/pubmed/id/19914138
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2010-2-17
|
pubmed:abstractText |
Posttransplant diabetes mellitus (PTDM) is a frequent complication among transplant recipients. Ligation of advanced glycation end products (AGEs) with their receptor (RAGE) on monocytes/macrophages plays roles in the diabetes complications. The enhancement of adhesion molecule expression on monocytes/macrophages activates T-cells, leading to reduced allograft survival. We investigated the effect of four distinct AGE subtypes (AGE-2/AGE-3/AGE-4/AGE-5) on the expressions of intracellular adhesion molecule (ICAM)-1, B7.1, B7.2 and CD40 on monocytes, the production of interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha and the proliferation of T-cells during human mixed lymphocyte reaction (MLR). AGE-2 and AGE-3 selectively induced the adhesion molecule expression, cytokine production and T-cell proliferation. The AGE-induced up-regulation of adhesion molecule expression was involved in the cytokine production and T-cell proliferation. AGE-2 and AGE-3 up-regulated the expression of RAGE on monocytes; therefore, the AGEs may activate monocytes, leading to the up-regulation of adhesion molecule expression, cytokine production and T-cell proliferation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cell Adhesion Molecules,
http://linkedlifedata.com/resource/pubmed/chemical/Glycosylation End Products, Advanced,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Immunologic,
http://linkedlifedata.com/resource/pubmed/chemical/advanced glycosylation end-product...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1521-7035
|
pubmed:author |
pubmed-author:LiuKeyueK,
pubmed-author:MatsudaHiroakiH,
pubmed-author:MoriShujiS,
pubmed-author:NishiboriMasahiroM,
pubmed-author:OhashiKatsuhisaK,
pubmed-author:SadamoriHiroshiH,
pubmed-author:TakahashiHideo KohkaHK,
pubmed-author:TanakaNoriakiN,
pubmed-author:WakeHidenoriH,
pubmed-author:YagiTakahitoT,
pubmed-author:YoshinoTadashiT
|
pubmed:copyrightInfo |
2009 Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
134
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
345-53
|
pubmed:meshHeading |
pubmed-meshheading:19914138-Cell Adhesion Molecules,
pubmed-meshheading:19914138-Flow Cytometry,
pubmed-meshheading:19914138-Glycosylation End Products, Advanced,
pubmed-meshheading:19914138-Humans,
pubmed-meshheading:19914138-Kinetics,
pubmed-meshheading:19914138-Lymphocyte Activation,
pubmed-meshheading:19914138-Lymphocyte Culture Test, Mixed,
pubmed-meshheading:19914138-Monocytes,
pubmed-meshheading:19914138-Receptors, Immunologic
|
pubmed:year |
2010
|
pubmed:articleTitle |
Advanced glycation end products enhance monocyte activation during human mixed lymphocyte reaction.
|
pubmed:affiliation |
Department of Gastroenterological Surgery, Transplant, and Surgical Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|